Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticholinergic agents in chronic bronchitis and emphysema.

N J Gross1

  • 1Department of Medicine, Stritch-Loyola School of Medicine, Maywood, Illinois.

Postgraduate Medical Journal
|January 1, 1987
PubMed
Summary

Inhaled anticholinergic agents effectively improve airflow in chronic bronchitis, offering a wider therapeutic margin than other bronchodilators. These agents are recommended as a first-line therapy for daily symptom relief in patients with chronic obstructive pulmonary disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Induced Incomitance of one Muscle Strabismus Surgery in Comparison to Unilateral Recess-Resect Procedures].

Klinische Monatsblatter fur Augenheilkunde·2015
Same author

[Perforating keratoplasty versus Descemet stripping automated endothelial keratoplasty in the partner eye: Functional results and patient satisfaction].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2015
Same author

[Prevalence of glaucoma in obstructive sleep apnea].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2015
Same author

Alternative mechanisms for tiotropium.

Pulmonary pharmacology & therapeutics·2009
Same author

Consensus statement: aerosols and delivery devices.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same author

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro.

FEBS letters·2008

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic bronchitis and emphysema are obstructive airway diseases.
  • Adrenergic agents are often less effective bronchodilators in these conditions.

Purpose of the Study:

  • To evaluate the efficacy of inhaled anticholinergic agents in chronic bronchitis.
  • To compare anticholinergic efficacy with adrenergic agents in obstructive airway diseases.

Main Methods:

  • Review of studies on inhaled anticholinergic and adrenergic agents in chronic bronchitis and emphysema.
  • Analysis of bronchodilator effects on FEV1 and specific airways conductance.

Main Results:

  • Anticholinergic agents provide a significant increase in airflow (FEV1) comparable to asthma.

Related Experiment Videos

  • Anticholinergics are more potent bronchodilators than adrenergic agents in bronchitis and emphysema.
  • Quaternary anticholinergics like ipratropium offer a wide therapeutic margin with minimal systemic side effects.

    • Conclusions:

    • Inhaled anticholinergic agents are a suitable first-line therapy for daily symptom management in chronic bronchitis.
    • Their favorable safety profile makes them ideal for the elderly population prevalent in chronic bronchitis.
    • Anticholinergics may play a role in managing acute exacerbations, though further research is needed.